These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2652599)

  • 1. Urine sediment cytology in the management of renal allograft recipients.
    Madras PN; Simpson MA; Cornaby AJ; Dempsey RA; Clowes GH; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1842-3. PubMed ID: 2652599
    [No Abstract]   [Full Text] [Related]  

  • 2. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients.
    Colvin RB; Preffer FI; Fuller T; Brown M; Ip S; Kung P; Cosimi AB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1863. PubMed ID: 2652605
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
    Cornaby AJ; Simpson MA; Madras PN; Dempsey RA; Clowes GH; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1861-2. PubMed ID: 2652604
    [No Abstract]   [Full Text] [Related]  

  • 4. Origin of elevated IL-2 and IL-2R in the urine of rejecting renal allograft recipients.
    Simpson MA; Madras PN; Cornaby AJ; Dempsey RA; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):299-300. PubMed ID: 2650126
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients.
    Cornaby A; Simpson M; Vann Rice R; Dempsey R; Madras P; Jenkins R; Monaco A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):827-30. PubMed ID: 3291322
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients.
    Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL
    Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of serum interleukin 2 receptor levels in renal allograft recipients.
    Plaza JJ; Blum G; Ortiz A; Hernando L; Feijoo E; Sanz J; Garcia R; Egido J; Ortiz F
    Transplant Proc; 1992 Feb; 24(1):63-4. PubMed ID: 1539346
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring the renal allograft by immunofluorescence of tubular epithelial cells in the urine sediment.
    Madras PN; Simpson MA; Monaco AP
    Transplant Proc; 1984 Dec; 16(6):1583-5. PubMed ID: 6390866
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between urine sediment cytology analysis and clinical state in cyclosporine-treated renal recipients.
    Madras PN; Simpson MA; Georgi BA; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1664. PubMed ID: 3274401
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytologic examination of urinary sediment in renal allograft recipients.
    Simpson MA; Madras PN; Monaco AP
    Transplant Proc; 1989 Aug; 21(4):3578-80. PubMed ID: 2669247
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients.
    Noronha IL; Daniel V; Rambausek M; Waldherr R; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1859-60. PubMed ID: 2117814
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of soluble IL-2 receptors in kidney graft recipients--a 6-month follow-up.
    Manfro RC; Pohanka E; Tomlanovich SJ; Benet LZ; Salvatierra O; Garovoy MR
    Transplant Proc; 1990 Aug; 22(4):1861-2. PubMed ID: 2389461
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-2 receptor positive cell levels in cyclosporin-versus azathioprine-treated renal transplant patients.
    Möhring K; Pomer S; Daniel U; Rambausek M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1469. PubMed ID: 2652470
    [No Abstract]   [Full Text] [Related]  

  • 14. The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology.
    Williamson EP; Millar RJ; Criddle RA; Sells RA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1785-6. PubMed ID: 3274423
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients.
    Beksaç M; Dalva K; Gönenç F; Dalva I; Gariboğlu S; Batur N; Cetin S
    Transplant Proc; 1993 Apr; 25(2):2145-7. PubMed ID: 8470296
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
    Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal tubular cells express ICAM-1 during allograft rejection.
    Chan RD; Greenstein SM; Tellis V; Corey HE
    Transplant Proc; 1993 Feb; 25(1 Pt 2):915-6. PubMed ID: 8095113
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibody identification of nucleated cells in urine: diagnosis of allograft rejection.
    Segasothy M; Birch DF; Fairley KF; Kincaid-Smith P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1878-9. PubMed ID: 2652610
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urine cytology in early diagnosis of acute rejection after renal transplantation (author's transl)].
    Wang QT
    Zhonghua Wai Ke Za Zhi; 1979; 17(6):443-6. PubMed ID: 400349
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of urine cytology versus fine needle aspiration cytology in monitoring renal allograft dysfunction.
    Spohn B; Bauer H; Gmähle E; Guth R; Franz HE
    Proc Eur Dial Transplant Assoc; 1983; 19():495-9. PubMed ID: 6348750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.